Matthew Q. Schmidt

Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor

B. Chin, Matthew Q. Schmidt, Zachary Trenbeath, 2019, World journal of nuclear medicine.

Evaluating Novel PET-CT Functional Parameters TLG and TMTV in Differentiating Low-grade Versus Grade 3A Follicular Lymphoma.

Diana Abbott, A. Hammes, M. Kamdar, 2019, Clinical lymphoma, myeloma & leukemia.

Predictors of survival in head and neck mucosal melanoma.

A. Ho, Z. Zumsteg, A. Mita, 2017, Oral oncology.

Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer

W. Hartsell, S. Keole, C. Vargas, 2018, Advances in radiation oncology.

Absent Cerebellar Circulation With Intact Cerebral Blood Flow on a 99mTc Bicisate "Brain Death" Study.

F. Schraml, Matthew Q. Schmidt, 2017, Clinical nuclear medicine.

18F-fluorodeoxyglucose positron emission tomography/ computed tomography in the diagnosis of a rare mycotic aneurysm of the thoracic aorta in a patient with fever of unknown origin

J. Kwak, Matthew Q. Schmidt, Rola Altoos, 2021, World journal of nuclear medicine.